BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23096424)

  • 1. Emergency management of acute urinary retention: results from an all-Ireland urologist practice survey.
    Cullen IM; Dowling CM; Thornhill JA; Grainger R
    Ir J Med Sci; 2013 Jun; 182(2):207-11. PubMed ID: 23096424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.
    Manikandan R; Srirangam SJ; O'Reilly PH; Collins GN
    BJU Int; 2004 Jan; 93(1):84-8. PubMed ID: 14678374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of conservatively managed acute urinary retention: prostate size matters.
    Kumar V; Marr C; Bhuvangiri A; Irwin P
    BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission of patients with acute urinary retention leads to a definitive management decision.
    Ryan PC; Ryan ÉJ; Keenan RA; Haroon UM; Broe MP; Forde JC; Galvin D; Lennon GM; Murphy M; Quinlan DM; Mulvin DW
    Ir J Med Sci; 2020 Aug; 189(3):999-1003. PubMed ID: 31858451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis on management of acute urinary retention.
    Yoon PD; Chalasani V; Woo HH
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
    Pandit RK; Agrawal CS; Chalise PR; Sapkota G
    Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
    Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
    Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best nonsurgical managements of acute urinary retention: what's new?
    Baboudjian M; Peyronnet B; Boissier R; Robert G; Cornu JN; Misrai V; Pradere B
    Curr Opin Urol; 2022 Mar; 32(2):124-130. PubMed ID: 34954701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
    Lo KL; Chan MC; Wong A; Hou SM; Ng CF
    Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acute urinary retention on the results of transurethral resection of the prostate.
    Baran C
    Urologia; 2023 Nov; 90(4):642-646. PubMed ID: 37491943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does acute urinary retention respond to alpha-blockers alone?
    McNeill SA
    Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.